Targeting the microenvironment of vulnerable atherosclerotic plaques: an emerging diagnosis and therapy strategy for atherosclerosis
Atherosclerosis is considered one of the primary causes of cardiovascular diseases (CVDs).
Unpredictable rupture of the vulnerable atherosclerotic plaques triggers adverse …
Unpredictable rupture of the vulnerable atherosclerotic plaques triggers adverse …
Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis
Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation in arteries,
leading to narrowing and thrombosis. It affects the heart, brain, and peripheral vessels and is …
leading to narrowing and thrombosis. It affects the heart, brain, and peripheral vessels and is …
Targeting Theranostics of Atherosclerosis by Dual‐Responsive Nanoplatform via Photoacoustic Imaging and Three‐In‐One Integrated Lipid Management
Atherosclerosis, as a life‐threatening cardiovascular disease with chronic inflammation and
abnormal lipid enrichment, is often difficult to treat timely due to the lack of obvious …
abnormal lipid enrichment, is often difficult to treat timely due to the lack of obvious …
Recent Progress in in vitro Models for Atherosclerosis Studies
Atherosclerosis is the primary cause of hardening and narrowing arteries, leading to
cardiovascular disease accounting for the high mortality in the United States. For developing …
cardiovascular disease accounting for the high mortality in the United States. For developing …
Nanodiscs: Game changer nano-therapeutics and structural biology tools
In recent years, engineering biocompatible HDL nanodiscs has garnered a great interest
with wide applications for for both drug delivery and structural biology. In this review, we …
with wide applications for for both drug delivery and structural biology. In this review, we …
Disrupted lipid metabolism in multiple sclerosis: a role for liver X receptors?
I Pineda-Torra, S Siddique, KE Waddington… - Frontiers in …, 2021 - frontiersin.org
Multiple sclerosis (MS) is a chronic neurological disease driven by autoimmune,
inflammatory and neurodegenerative processes leading to neuronal demyelination and …
inflammatory and neurodegenerative processes leading to neuronal demyelination and …
Immune Implications of Cholesterol-Containing Lipid Nanoparticles
The majority of clinically approved nanoparticle-mediated therapeutics are lipid
nanoparticles (LNPs), and most of these LNPs are liposomes containing cholesterol. LNP …
nanoparticles (LNPs), and most of these LNPs are liposomes containing cholesterol. LNP …
Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation
Background Atherosclerosis-related cardiovascular diseases (CVDs) are the leading cause
of mortality worldwide. Cholesterol crystals (CCs) induce inflammation in atherosclerosis …
of mortality worldwide. Cholesterol crystals (CCs) induce inflammation in atherosclerosis …
Advances in imaging and treatment of atherosclerosis based on organic nanoparticles
S Tu, W He, J Han, A Wu, W Ren - APL bioengineering, 2022 - pubs.aip.org
Atherosclerosis, a systemic chronic inflammatory disease, can lead to thrombosis and
vascular occlusion, thereby inducing a series of serious vascular diseases. Currently …
vascular occlusion, thereby inducing a series of serious vascular diseases. Currently …
Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders
A Zaid, A Ariel - Advanced Drug Delivery Reviews, 2024 - Elsevier
Targeting specific organs and cell types using nanotechnology and sophisticated delivery
methods has been at the forefront of applicative biomedical sciences lately. Macrophages …
methods has been at the forefront of applicative biomedical sciences lately. Macrophages …